MetLife Investment Management, LLC AXSM Holdings History
MetLife Investment Management, LLC's Axsome Therapeutics Inc Holding Summary
As of 2025-03-31, MetLife Investment Management, LLC held 178,955.00 shares of Axsome Therapeutics Inc(AXSM), totaling $20.87 Mil. This investment constitutes 0.11% of their stock portfolio, and MetLife Investment Management, LLC now holds 0.36% of the outstanding Axsome Therapeutics Inc(AXSM) stock.
The initial trade took place in 2019Q2. And since then MetLife Investment Management, LLC has made 10 purchases of AXSM, at an average price of $103.45, for a total of 182,391.00 shares. In addition, there have been 3 sales at an average price of $57.36 for 3,436.00 shares. Based on historical transaction data and AXSM's current price of $108.41, MetLife Investment Management, LLC's estimated gain on his AXSM holdings is $728,417.39, reflecting a 3.86% gain to date.
MetLife Investment Management, LLC AXSM ($108.41) Holding Chart
MetLife Investment Management, LLC AXSM ($108.41) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
